EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
暂无分享,去创建一个
A. Warth | H. Dienemann | W. Weichert | P. Schirmacher | A. Stenzinger | R. Penzel | Michael Thomas | F. Herth | P. Schnabel | T. Muley | B. Goeppert | E. Herpel | H. Hoffmann | H. Lindenmaier | R. Brandt